{"schema_version":"secwatch.filing_event.v1","accession":"0001386570-26-000003","form_type":"8-K","ticker":"NAGE","cik":"0001386570","company_name":"Niagen Bioscience, Inc.","filed_at":"2026-02-26T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.963523+00:00","generated_at":"2026-05-15T23:29:18.246603+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"medium","headline":"Niagen Bioscience sells ChromaDex Reference Standards business to LGC in all-cash deal","bullets":["All-cash sale closed Feb 24, 2026; buyer is VHG Labs, part of LGC Group.","Divestiture exits non-core activities; focuses on NAD+ science, IP, commercial growth.","Transition services agreement for up to 6 months; service fee recognized as performed.","No purchase price or financial terms disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001386570-26-000003","json":"https://secwatch.observer/filing/0001386570-26-000003.json","markdown":"https://secwatch.observer/filing/0001386570-26-000003.md","text":"https://secwatch.observer/filing/0001386570-26-000003.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1386570/000138657026000003/0001386570-26-000003-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1386570/000138657026000003/cdxc-20260224.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T23:29:18.246603+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}